Shanghai InnoStar Bio-tech Co., Ltd. (SHA:688710)
67.03
0.00 (0.00%)
At close: May 6, 2026
SHA:688710 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,342 | 1,287 | 1,370 | 1,158 | 1,255 | 638.77 |
Short-Term Investments | - | - | - | - | - | 12.33 |
Cash & Short-Term Investments | 1,342 | 1,287 | 1,370 | 1,158 | 1,255 | 651.1 |
Cash Growth | 2.07% | -6.02% | 18.25% | -7.69% | 92.70% | 223.82% |
Accounts Receivable | 336.65 | 329.62 | 359.88 | 273.91 | 228.07 | 139.5 |
Other Receivables | 8.48 | 8.26 | 22.74 | 17.81 | 6.06 | - |
Receivables | 345.13 | 337.88 | 382.62 | 291.72 | 234.13 | 139.54 |
Inventory | 441.26 | 430.46 | 332.02 | 510.54 | 489.47 | 396.85 |
Other Current Assets | 164.53 | 123.16 | 83.83 | 25.51 | 34.48 | 68.05 |
Total Current Assets | 2,293 | 2,179 | 2,168 | 1,986 | 2,013 | 1,256 |
Property, Plant & Equipment | 825.76 | 786.74 | 703.96 | 438.88 | 444.53 | 443.69 |
Other Intangible Assets | 102.72 | 103.57 | 105.52 | 109.47 | 10.91 | 5.39 |
Long-Term Deferred Tax Assets | 26.32 | 25.32 | 17.94 | 13.21 | 7.78 | 7.58 |
Long-Term Deferred Charges | 65.08 | 66.8 | 70.45 | 77.02 | 81.57 | 73.78 |
Other Long-Term Assets | 59.79 | 92.42 | 153.65 | 150.86 | 60.72 | 16.62 |
Total Assets | 3,372 | 3,253 | 3,220 | 2,775 | 2,618 | 1,803 |
Accounts Payable | 44.85 | 69 | 46.82 | 83.99 | 59.4 | 83.53 |
Accrued Expenses | 28.57 | 34.89 | 38.99 | 75.29 | 65.6 | 60.73 |
Short-Term Debt | - | - | 0.5 | 8.01 | - | - |
Current Portion of Long-Term Debt | 12.64 | 11.09 | - | - | - | 39.06 |
Current Portion of Leases | - | - | 29.28 | 23.39 | 17.57 | 17.91 |
Current Income Taxes Payable | 3.61 | 1.87 | 5.12 | 2.98 | 7.13 | 9.46 |
Current Unearned Revenue | 574.2 | 456.45 | 347.3 | 607.29 | 722 | 534.11 |
Other Current Liabilities | 143.78 | 138.89 | 100.35 | 80.36 | 30 | 20.76 |
Total Current Liabilities | 807.64 | 712.19 | 568.37 | 881.31 | 901.71 | 765.57 |
Long-Term Leases | 118.06 | 104.59 | 201.32 | 215.1 | 229.23 | 239.28 |
Long-Term Unearned Revenue | 66.05 | 68.47 | 41.34 | 38.78 | 45.76 | 43.34 |
Other Long-Term Liabilities | 4.52 | 6.16 | 6.39 | 0.76 | - | 0 |
Total Liabilities | 996.27 | 891.41 | 817.42 | 1,136 | 1,177 | 1,048 |
Common Stock | 140.98 | 140.98 | 140.98 | 105.73 | 105.73 | 87.13 |
Additional Paid-In Capital | 1,698 | 1,696 | 1,688 | 1,098 | 1,081 | 475.48 |
Retained Earnings | 499.18 | 486.97 | 562.6 | 414.83 | 220.38 | 134.38 |
Comprehensive Income & Other | -0.58 | -0.34 | 0.06 | - | - | - |
Total Common Equity | 2,338 | 2,323 | 2,392 | 1,618 | 1,407 | 696.99 |
Minority Interest | 38.59 | 38.58 | 10.19 | 21.42 | 34.35 | 57.43 |
Shareholders' Equity | 2,376 | 2,362 | 2,402 | 1,639 | 1,442 | 754.41 |
Total Liabilities & Equity | 3,372 | 3,253 | 3,220 | 2,775 | 2,618 | 1,803 |
Total Debt | 130.7 | 115.68 | 231.1 | 246.5 | 246.8 | 296.25 |
Net Cash (Debt) | 1,211 | 1,171 | 1,138 | 911.73 | 1,008 | 354.85 |
Net Cash Growth | 11.55% | 2.89% | 24.87% | -9.54% | 184.03% | 119.03% |
Net Cash Per Share | 8.77 | 8.45 | 9.71 | 8.63 | 10.42 | 4.83 |
Filing Date Shares Outstanding | 135.65 | 140.98 | 140.98 | 105.73 | 96.72 | 87.13 |
Total Common Shares Outstanding | 135.65 | 140.98 | 140.98 | 105.73 | 96.72 | 87.13 |
Working Capital | 1,485 | 1,466 | 1,600 | 1,105 | 1,111 | 489.97 |
Book Value Per Share | 17.23 | 16.48 | 16.97 | 15.30 | 14.55 | 8.00 |
Tangible Book Value | 2,235 | 2,220 | 2,286 | 1,509 | 1,396 | 691.59 |
Tangible Book Value Per Share | 16.47 | 15.75 | 16.22 | 14.27 | 14.44 | 7.94 |
Buildings | - | - | 103.59 | 44.04 | 25.53 | 24.35 |
Machinery | - | - | 379.74 | 316.83 | 288.03 | 223.18 |
Construction In Progress | - | - | 239.02 | 40.75 | 0.28 | 0.3 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.